PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 6 days 22 hours 11 minutes
Management of Patients With Untreated AML Ineligible for Intensive Remission Induction Therapy: Challenges and Opportunities
Go online to www.peervoice.com/h/pve52 to view the entire programme with slides.
Hedgehog Pathway Inhibitors for the Treatment of Advanced Basal Cell Carcinoma: Towards a Patient-Centred Approach
Go online to www.peervoice.com/h/pvr164 to view the entire programme with slides.
Insights and Strategies for Individualising Therapy for ALK-Positive NSCLC: Updates From Recent Medical Congresses
Go online to www.peervoice.com/h/pvs62 to view the entire programme with slides.
CD30+ T-Cell Lymphomas: Improving the Blueprint of Care
CD30+ T-Cell Lymphomas: Improving the Blueprint of Care
Second-Line Therapies for EGFR Wild-Type NSCLC: What Is the Best Treatment? That Is the Question!
Go online to www.peervoice.com/h/pve44 to view the entire programme with slides.
The Evolving Landscape in Targeted Therapy for Metastatic Colorectal Cancer: Impact of Recent Data on Practice and Patients
Go online to www.peervoice.com/h/pvs59 to view the entire programme with slides.
Optimal First-Line Treatment of EGFR-Mutation–Positive Non–Small-Cell Lung Cancer: What’s Changed for 2014?
Go online to www.peervoice.com/h/pve46 to view the entire programme with slides.
A Patient-Centered Approach to BRAFV600 Mutated Metastatic Melanoma: Expert Insights on Managing Patients With Confidence
Go online to www.peervoice.com/h/pvr138 to view the entire programme with slides.
Using Targeted Therapies to Overcome Radioactive Iodine Resistance in Advanced Differentiated Thyroid Cancer
Go online to www.peervoice.com/h/pvr147 to view the entire programme with slides.
The Case for New Combinations in Relapsed Multiple Myeloma: Finding the Perfect Therapeutic Fit for Your High-Risk Patient
The Case for New Combinations in Relapsed Multiple Myeloma: Finding the Perfect Therapeutic Fit for Your High-Risk Patient